Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
CC transcript
Appointed director
|
|
CAMBREX CORP (CBM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/07/2020 |
GN
| Cambrex Completes Biopharmaceutical Expansion at its Durham, NC Facility |
| 12/04/2019 |
GN
| Cambrex Announces Completion of Acquisition by the Permira Funds |
| 11/14/2019 |
GN
| Cambrex Wins Third API Development Award at CPhI Worldwide |
| 10/24/2019 |
GN
| Cambrex Releases Selected Preliminary Third Quarter 2019 Financial Results |
| 09/25/2019 |
GN
| Bragar Eagel & Squire, P.C. Announces that it is Investigating the Boards of Directors of Highlands, Cambrex, Two River, and Carbon Black on behalf of Stockholders and Encourages Investors to Contact the Firm |
| 09/23/2019 |
GN
| Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – NCI, CBM, VSI, WAIR |
| 09/23/2019 |
GN
| Cambrex Corporation Announces Expiration of “Go Shop” Period Under Merger Agreement |
| 09/17/2019 |
GN
| Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – CBM, WAIR, AVDR, PSDO |
| 09/11/2019 |
GN
| Bragar Eagel & Squire, P.C. Announces that it is Investigating the Boards of Directors of Cambrex, Presidio, Old Line Bancorp, and Milacron Holdings on behalf of Stockholders and Encourages Investors to Contact the Firm |
| 09/06/2019 |
GN
| SHAREHOLDER ALERT: WeissLaw LLP Reminds NRCG, NCI, CBM, and TRCB Shareholders About Its Ongoing Investigations |
| 09/04/2019 |
GN
| PVTL, CBM, VSI and AVDR SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts |
| 09/03/2019 |
GN
| Merger Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – MCRN, TYPE, GHDX, CBM |
| 08/19/2019 |
GN
| TRCB, VSI, CBM, and TRK SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts |
| 08/16/2019 |
GN
| SHAREHOLDER ALERT: WeissLaw LLP Reminds CBM, VSI and NCI Shareholders About Its Ongoing Investigations |
| 08/14/2019 |
GN
| Shareholder Investigation Alert: Halper Sadeh LLP is Investigating Whether The Sale of These Companies is Fair to Shareholders – CBM, GCI, WAIR, ACIA |
| 08/09/2019 |
GN
| Shareholder Investigation Alert: Halper Sadeh LLP is Investigating Whether The Sale of These Companies is Fair to Shareholders – GCI, CBM, CVRS, VSI |
| 08/08/2019 |
GN
| MERGER ALERT – NCI, GCI, and CBM: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies |
| 08/07/2019 |
GN
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Cambrex Corporation to the Permira funds is Fair to Shareholders |
| 08/07/2019 |
GN
| Cambrex Cancels Second Quarter Earnings Conference Call and Will Not Update Financial Guidance |
| 08/07/2019 |
GN
| Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash |
| 08/06/2019 |
GN
| Cambrex to Announce Second Quarter 2019 Financial Results on August 9, 2019 |
| 07/30/2019 |
GN
| Cambrex to Double Size of Edinburgh Solid Form Screening Facility |
| 06/04/2019 |
GN
| Cambrex Completes New Process and Analytical Development Facility at its Karlskoga, Sweden Manufacturing Site |
| 05/29/2019 |
GN
| Cambrex to Present at Upcoming Investor Conferences in June |
| 05/02/2019 |
GN
| Cambrex Reports First Quarter 2019 Financial Results |
| 04/30/2019 |
GN
| Cambrex to Announce First Quarter 2019 Financial Results on May 2, 2019 |
| 04/23/2019 |
GN
| Cambrex Completes New Quality Control Laboratory for Generic API Development in Milan |
| 04/10/2019 |
GN
| Cambrex Completes Highly Potent API Manufacturing Facility at Charles City, IA |
| 03/26/2019 |
GN
| Cambrex Doubles cGMP Liquid Filling Capacity at its Mirabel, Québec Facility |
| 02/13/2019 |
GN
| Cambrex Reports Fourth Quarter and Full Year 2018 Financial Results |
| 02/08/2019 |
GN
| Cambrex to Announce Fourth Quarter and Full Year 2018 Financial Results on February 13, 2019 |
| 01/02/2019 |
GN
| Cambrex Completes Acquisition of Avista Pharma Solutions |
| 12/11/2018 |
GN
| Cambrex Expands Analytical Capabilities at its High Point, NC Site |
| 11/20/2018 |
GN
| Cambrex to Acquire Avista Pharma Solutions, Adding Early Stage API and Finished Dosage Form Development & Testing Services to its Global Contract Development & Manufacturing Network |
|
|
|